Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

NCT00006026 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

Interventions

DRUG: rubitecan

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC